SCHEMBL17157940

SCHEMBL17157940

O=C(O)C(=O)/C=C/c1ccc(Br)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.50
▸ AKR1C2 P52895 1/20 0.50
▸ MAOB P27338 5/20 0.43
▸ MAOA P21397 4/20 0.43
▸ HSD17B3 P37058 1/20 0.41
▸ GABBR2 O75899 1/20 0.41
▸ GABBR1 Q9UBS5 1/20 0.41
▸ PRMT1 Q99873 1/20 0.40
▸ EGFR P00533 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ SNCA P37840 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17157941 1.00 AKR1C3 (0.50) AKR1C3AKR1C2MAOBMAOAHSD17B3
SCHEMBL2571095 0.86 AKR1C3 (0.67) AKR1C3AKR1C2MAOBMAOAHSD17B3
SCHEMBL2571093 0.86 AKR1C3 (0.67) AKR1C3AKR1C2MAOBMAOAHSD17B3
SCHEMBL17158057 0.81 BACE1 (0.42) AKR1C3AKR1C2MAOBMAOAMAPT
SCHEMBL17158058 0.81 BACE1 (0.42) AKR1C3AKR1C2MAOBMAOAMAPT
SCHEMBL28735753 0.78 TTR (0.58) AKR1C3AKR1C2MAOBMAOAMAPT
SCHEMBL30842600 0.77 GABBR2 (0.44) MAOBMAOAGABBR2GABBR1MAPT
SCHEMBL14542110 0.76 NFE2L2 (0.59) MAOBMAOAMAPTALDH1A1KDM4E
SCHEMBL29162914 0.76 HSD17B3 (0.71) MAOBMAOAHSD17B3MAPTALDH1A1
SCHEMBL27488322 0.75 AKR1C3 (0.43) AKR1C3AKR1C2MAOBMAOAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376420-B2 4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same YUHAN CORPORATION (KR) 2016-06-28 — — US disclosed
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME YUHAN CORPORATION (KR) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME NR1H3, NR1H2, NR1H4 AKR1C3 1051/4885AKR1C2 844/4885MAOB 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback